Radioactive Iodine-131 Treatment for Differentiated Thyroid Carcinoma_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

黄蕤 , 李林

Corresponding author：

Keywords：

分化型甲状腺癌; 放射性碘-131; 治疗

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 黄蕤,李林. Radioactive Iodine-131 Treatment for Differentiated Thyroid Carcinoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2012, 19(8): 814-817. doi: Copy

1.	Schlumberger MJ. Papillary and follicular thyroid carcinoma[J]. N Engl J Med， 1998， 338(5)：297-306.
2.	Siegel R， Ward E， Brawley O， et al. Cancer statistics， 2011：the impact of eliminating socioeconomic and racial disparities on premature cancer deaths[J]. CA Cancer J Clin， 2011， 61(4)：212-236.
3.	Wang Y， Wang W. Increasing incidence of thyroid cancer in Shanghai， China， 1983-2007[J]. Asia Pac J Public Health， 2012， Mar 16. [Epub ahead of print].
4.	钱碧云，何敏，陈可欣，等. 天津城市居民甲状腺乳头状癌发病率和构成比的长期时间趋势分析[J]. 中国实用外科杂志， 2011， 31(5)：420-422.
5.	Becker DV， Clark TS. Radioiodine and thyroid disease：the beginning[J]. Semin Nucl Med， 1996， 26(3)：155-164.
6.	Cooper DS， Doherty GM， Haugen BR， et al. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid， 2009， 19(11)：1167-1214.
7.	Taylor T， Specker B， Robbins J， et al. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma[J]. Ann intern Med， 1998， 129(8)：62-627.
8.	Tsang RW， Brierley JD， Simpson WJ， et al. The effects of surgery， radioiodine， and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma[J]. Cancer， 1998， 82(2)：375-388.
9.	Mazzaferri EL， Kloos RT. Clinical review 128：Current approaches to primary therapy for papillary and follicular thyroid cancer[J]. J Clin Endocrinol Metab， 2001， 86(4)：1447-1463.
10.	Wartofsky L， Sherman Si， Gopal J， et al. The use of radioactive iodine in patients with papillary and follicular thyroid cancer[J]. J Clin Endocrinol Metab， 1998， 83(12)：4195-4203.
11.	Jonklaas J， Sarlis NJ， Litofsky D， et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy[J]. Thyroid， 2006， 16(12)：1229-1242.
12.	匡安仁. 131I治疗分化型甲状腺癌[A]//临床技术操作规范-核医学分册[M]. 北京：人民军医出版社， 2004：178-180.
13.	Padovani R， Kasamatsu TS， Nakabashi CC， et al. One month is sufficient for urinary iodine to return to its baseline value after the use of water soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy[J]. Thyroid， 2012， Jun 6. [Epub ahead of print].
14.	Hocevar M， Auersperg M， Stanovnik L. The dynamics of serum thyroglobulin elimination from the body after thyroid surgery[J]. Eur J Surg Oncol， 1997， 23(3)：208-210.
15.	何英，潘明志，戚忠智. 131I-SPECT/CT融合显像诊断分化型甲状腺癌转移灶的临床价值[J]. 四川大学学报（医学版）， 2010， 41(4)：734-736.

1. Schlumberger MJ. Papillary and follicular thyroid carcinoma[J]. N Engl J Med， 1998， 338(5)：297-306.
2. Siegel R， Ward E， Brawley O， et al. Cancer statistics， 2011：the impact of eliminating socioeconomic and racial disparities on premature cancer deaths[J]. CA Cancer J Clin， 2011， 61(4)：212-236.
3. Wang Y， Wang W. Increasing incidence of thyroid cancer in Shanghai， China， 1983-2007[J]. Asia Pac J Public Health， 2012， Mar 16. [Epub ahead of print].
4. 钱碧云，何敏，陈可欣，等. 天津城市居民甲状腺乳头状癌发病率和构成比的长期时间趋势分析[J]. 中国实用外科杂志， 2011， 31(5)：420-422.
5. Becker DV， Clark TS. Radioiodine and thyroid disease：the beginning[J]. Semin Nucl Med， 1996， 26(3)：155-164.
6. Cooper DS， Doherty GM， Haugen BR， et al. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid， 2009， 19(11)：1167-1214.
7. Taylor T， Specker B， Robbins J， et al. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma[J]. Ann intern Med， 1998， 129(8)：62-627.
8. Tsang RW， Brierley JD， Simpson WJ， et al. The effects of surgery， radioiodine， and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma[J]. Cancer， 1998， 82(2)：375-388.
9. Mazzaferri EL， Kloos RT. Clinical review 128：Current approaches to primary therapy for papillary and follicular thyroid cancer[J]. J Clin Endocrinol Metab， 2001， 86(4)：1447-1463.
10. Wartofsky L， Sherman Si， Gopal J， et al. The use of radioactive iodine in patients with papillary and follicular thyroid cancer[J]. J Clin Endocrinol Metab， 1998， 83(12)：4195-4203.
11. Jonklaas J， Sarlis NJ， Litofsky D， et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy[J]. Thyroid， 2006， 16(12)：1229-1242.
12. 匡安仁. 131I治疗分化型甲状腺癌[A]//临床技术操作规范-核医学分册[M]. 北京：人民军医出版社， 2004：178-180.
13. Padovani R， Kasamatsu TS， Nakabashi CC， et al. One month is sufficient for urinary iodine to return to its baseline value after the use of water soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy[J]. Thyroid， 2012， Jun 6. [Epub ahead of print].
14. Hocevar M， Auersperg M， Stanovnik L. The dynamics of serum thyroglobulin elimination from the body after thyroid surgery[J]. Eur J Surg Oncol， 1997， 23(3)：208-210.
15. 何英，潘明志，戚忠智. 131I-SPECT/CT融合显像诊断分化型甲状腺癌转移灶的临床价值[J]. 四川大学学报（医学版）， 2010， 41(4)：734-736.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Radioactive Iodine-131 Treatment for Differentiated Thyroid Carcinoma

Abstract Full text Figures/Tables Video References Cited by

Format

Content